guanethidine has been researched along with Batten Turner Congenital Myopathy in 2 studies
Guanethidine: An antihypertensive agent that acts by inhibiting selectively transmission in post-ganglionic adrenergic nerves. It is believed to act mainly by preventing the release of norepinephrine at nerve endings and causes depletion of norepinephrine in peripheral sympathetic nerve terminals as well as in tissues.
guanethidine : A member of the class of guanidines in which one of the hydrogens of the amino group has been replaced by a 2-azocan-1-ylethyl group.
guanethidine sulfate : A organic sulfate salt composed of two molecules of guanethidine and one of sulfuric acid.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kirby, JF | 1 |
| Kraft, GH | 1 |
| Huber, A | 1 |
2 other studies available for guanethidine and Batten Turner Congenital Myopathy
| Article | Year |
|---|---|
Electromyographic studies in myotonia congenita.
Topics: Action Potentials; Adult; Cell Membrane Permeability; Electric Stimulation; Electromyography; Evoked | 1973 |
[Therapy of oculomotor muscle paralysis].
Topics: Administration, Topical; Anti-Inflammatory Agents; Guanethidine; Humans; Myasthenia Gravis; Myositis | 1968 |